Konrad Koehler joined Beactica Therapeutics in 2015 and was promoted to Head of Discovery in 2020. He has over 25 years of industrial drug discovery experience having worked at Karo Bio AB, Solvay Pharmaceuticals GmbH, Merck Italia and Searle R&D. During his career, he was instrumental in establishing drug discovery collaborations which resulted in four drug candidates that underwent clinical trials. Konrad was a Postdoctoral Research Scholar at Stanford University and holds a Ph.D. in Organic Chemistry from Emory University.
Sign up for the Beactica newsletter to receive our latest news and updates